PubMed=9973934; DOI=10.1016/S0165-4608(98)00122-8
Nelson M.A., Ariza M.E., Yang J.-M., Thompson F.H., Taetle R., Trent J.M., Wymer J., Massey-Brown K.S., Broome-Powell M., Easton J., Lahti J.M., Kidd V.J.
Abnormalities in the p34cdc2-related PITSLRE protein kinase gene complex (CDC2L) on chromosome band 1p36 in melanoma.
Cancer Genet. Cytogenet. 108:91-99(1999)

PubMed=10497214; DOI=10.1074/jbc.274.40.28505
Ariza M.E., Broome-Powell M., Lahti J.M., Kidd V.J., Nelson M.A.
Fas-induced apoptosis in human malignant melanoma cell lines is associated with the activation of the p34(cdc2)-related PITSLRE protein kinases.
J. Biol. Chem. 274:28505-28513(1999)

PubMed=12115485; DOI=10.1002/ijc.10422
Feng Y.-M., Shi J.-Q., Goldstein A.M., Tucker M.A., Nelson M.A.
Analysis of mutations and identification of several polymorphisms in the putative promoter region of the P34CDC2-related CDC2L1 gene located at 1P36 in melanoma cell lines and melanoma families.
Int. J. Cancer 99:834-838(2002)

PubMed=19383853; DOI=10.1158/1535-7163.MCT-08-1030; PMCID=PMC3128982
Su D.M., Zhang Q.-Y., Wang X.-X., He P., Zhu Y.-L.J., Zhao J.-X., Rennert O.M., Su Y.A.
Two types of human malignant melanoma cell lines revealed by expression patterns of mitochondrial and survival-apoptosis genes: implications for malignant melanoma therapy.
Mol. Cancer Ther. 8:1292-1304(2009)